A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2004
11/11/2004	WO2004096851A1 Galectin 9-inducing factor
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096797A1 Inhibitors of phosphatidylinositol 3-kinase
11/11/2004	WO2004096275A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096247A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096230A1 Remedy for rheumatoid arthritis
11/11/2004	WO2004096227A1 Pharmaceutical compositon comprising a cathepsin s inhibitor and an opioid
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004096206A2 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor
11/11/2004	WO2004075864A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
11/11/2004	WO2004071517A3 Uses of il-23 related reagents
11/11/2004	WO2004069240A3 Use in therapy of endocannabinoid-like compounds
11/11/2004	WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	US20040225140 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040225021 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224992 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224978 CCR8 inhibitors
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224968 Drugs for treatment of tumors, antidiabetic agents, antiproliferation agents and injections
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	US20040224942 Use of N-desmethylclozapine to treat human neuropsychiatric disease
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224938 Substituted benzo [b] azepin-2-one compounds
11/11/2004	US20040224932 crystal structure; antiinflammatory agents; antiallergens
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents
11/11/2004	US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	US20040223911 Stabilized therapeutic and imaging agents
11/11/2004	DE10257824B4 Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen Composition for the treatment of pain, particularly for the treatment of joint pain
11/11/2004	CA2523508A1 Galectin 9-inducing factors
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2522817A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	CA2521741A1 Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid
11/10/2004	EP1475386A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
11/10/2004	EP1475377A1 Derivatives of indole and their use as phosphodiesterase 4 inhibitors
11/10/2004	EP1475376A1 Hair composition containing a pyrimidine-n-oxide derivative and its use to stimulate keratinic fiberes growth and/or preventing their loss
11/10/2004	EP1475091A1 Mycophenolate mofetil - high dose oral suspensions
11/10/2004	EP1475088A1 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract
11/10/2004	EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474393A1 Aryl ureas as kinase inhibitors
11/10/2004	EP1474392A1 Polymorphic form xvi of fexofenadine hydrochloride
11/10/2004	EP1474391A1 Water soluble phenylglycine derivatives
11/10/2004	EP1474168A1 7s immunoglobulin for treatment of choroidal neovascularisation
11/10/2004	EP1474159A2 Compositions containing oat straw and willowherb extract
11/10/2004	EP1474149A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474136A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474116A1 Colonic release composition
11/10/2004	EP1474109A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2004	EP1474108A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1259515B1 Thienopyridine derivatives and their use as anti-inflammatory agents
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	EP1240172B1 New aminopropylphosphinic acids
11/10/2004	EP1131050B8 Galenic formulations fast disintegrating in the mouth and method for preparing same
11/10/2004	EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545415A Bone anabolic compounds and methods of use
11/10/2004	CN1545407A Transdermal therapeutic system (TTS) with fentanyl as active ingredient
11/10/2004	CN1544471A Bovine mastitis resistant yolk antibody and its preparation method and formulation
11/10/2004	CN1544461A Uro-genital condition treatment system
11/10/2004	CN1544425A Daphnetin derivative
11/10/2004	CN1544086A Application of apolipoprotein A-I in the preparing process for medicine capable of resisting endotoxin and inhibiting cytokine release
11/10/2004	CN1544067A Effervescence tablet of radix isatidis and its preparation
11/10/2004	CN1544065A Effervescence tablet for treating cold and fever and its preparation
11/10/2004	CN1544064A Freeze-dried 'Shengmai' powder for injection and its preparing process
11/10/2004	CN1544054A Oral liquid for treating numbness pain

1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 1272